Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228689 · ClinicalTrials.gov registry record
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
A clinical trial of Gastrointestinal Neoplasm and Mass Lesion, sponsored by Orlando Health.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07228689 is a study of Gastrointestinal Neoplasm and Mass Lesion that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 200 participants, above the 66-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (203% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07228689, a study of Gastrointestinal Neoplasm and Mass Lesion, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST EUS-guided fine needle biopsy
Study Locations (1)
Florida
- Orlando Health Digestive Health Institute - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07228689
The ClinicalTrials.gov registry entry for NCT07228689 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 66-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (203% higher). The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastrointestinal Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which EUS-guided fine needle biopsy is the first listed.
NCT07228689 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07228689 about?
NCT07228689 is a clinical study titled "AI for Onsite Cytology Evaluation in Endoscopic Ultrasound". The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologist...
What is the current status of trial NCT07228689?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-11-12. Estimated completion is 2027-10.
What conditions does trial NCT07228689 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasm, Mass Lesion.
What interventions are being tested in trial NCT07228689?
The interventions under investigation include: EUS-guided fine needle biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07228689?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07228689 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
RECRUITING · NA
-
Traction vs. No Traction in Colonic ESD
RECRUITING · NA
-
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
COMPLETED · Phase 1
-
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.